VeriMommyristoyl octapeptide-31 hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment flagging reproductive hazard. Peer‑reviewed literature and public databases (PubChem, CosIng) contain no reproductive toxicity or teratogenicity data for myristoyl octapeptide‑31. As an acylated cosmetic peptide with increased lipophilicity vs the parent peptide, topical absorption is plausible but expected to be low for typical cosmetic use (hence exposure = 1). Sources consulted: ECHA Annex VI (no harmonised CLP), CosIng, PubChem, PubMed (no reproductive studies found), CIR (no assessment).
Related ingredients
Frequently asked questions
- myristoyl octapeptide-31 hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment flagging reproductive hazard. Peer‑reviewed literature and public databases (PubChem, CosIng) contain no reproductive toxicity or teratogenicity data for myristoyl octapeptide‑31. As an acylated cosmetic peptide with increased lipophilicity vs the parent peptide, topical absorption is plausible but expected to be low for typical cosmetic use (hence exposure = 1). Sources consulted: ECHA Annex VI (no harmonised CLP), CosIng, PubChem, PubMed (no reproductive studies found), CIR (no assessment).
- myristoyl octapeptide-31 emzirirken güvenli mi?
- No data indicating damage to lactation or transfer into breastmilk; no harmonised classification or regulatory safety warnings. By analogy to other topical peptides and given modest dermal absorption potential, low but measurable exposure is assumed during topical use. Same data sources as for pregnancy show no reproductive/lactation concerns.
- myristoyl octapeptide-31 bebek cildi için güvenli mi?
- No infant‑specific toxicology or dermal absorption studies identified. Because infant skin (0–3 yr) has higher surface‑area‑to‑bodyweight and a less mature barrier, dermal exposure was conservatively increased by one exposure level versus adults (adult e=1 → baby e=2). No evidence suggests increased inherent reproductive or mechanistic hazard to infants.
- VeriMom myristoyl octapeptide-31 nasıl puanlıyor?
- VeriMom myristoyl octapeptide-31'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte myristoyl octapeptide-31 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.